CMIC：2019年药物开发与制造：挑战与机遇报告（英文版）

QUESTION :In 2007, CMIc acquired a manufacturingplant in New Jersey. That early acquisition became CMICCMO USA, a contract service provider for oral solid drugmanufacturing. What has changed for the Us part of thecompany?

MAKOTO MATSUKAWA: The original purpose of CMIC CMOwas to support US-based pharma companies. For the smallto mid-sized pharmaceutical companies interested in prod.uct development for the US and the Japanese markets, itis preferable to connect with a cDMO operating in bo